Unconventional microbial systems for the cost-efficient production of high-quality protein therapeutics

Corchero, José Luis, Gasser, Brigitte, Resina, David, Smith, Wesley, Parrilli, Ermenegilda, Vázquez, Felícitas, Abasolo, Ibane, Giuliani, Maria +7 more·2013·Biotechnology Advances
DOI 10.1016/j.biotechadv.2012.09.001

Cites (266)

Items 201–259 of 259

  1. High-level production of animal-free recombinant transferrin from saccharomyces cerevisiae
    Christopher J. A. Finnis, Tom Payne, Joanna Hay, Neil Dodsworth, Diane Wilkinson, Philip H. Morton, Malcolm J. Saxton, David Tooth, Robert W. Evans, Hans Goldenberg et al. · 2010 · Microbial Cell Factories
  2. Formulation Development for Hydrophobic Therapeutic Proteins
    Andrea Hawe, Wolfgang Frieß · 2007 · Pharmaceutical Development and Technology
  3. Consortium of fold-catalyzing proteins increases soluble expression of cyclohexanone monooxygenase in recombinant Escherichia coli
    D.-H. Lee, M.-D. Kim, WonJune Lee, Dae‐Hyuk Kweon, Jin‐Ho Seo · 2004 · Applied Microbiology and Biotechnology
  4. Promoters from a cold-adapted bacterium: definition of a consensus motif and molecular characterization of UP regulative elements
    Angela Duilio, Stefania Madonna, Maria Luisa Tutino, Marinella Pirozzi, Giovanni Sannia, Gennaro Marino · 2004 · Extremophiles
  5. The Functional Quality of Soluble Recombinant Polypeptides Produced in Escherichia coli Is Defined by a Wide Conformational Spectrum
    Mónica Martínez‐Alonso, Núria González‐Montalbán, Elena García‐Fruitós, Antonio Villaverde · 2008 · Applied and Environmental Microbiology
  6. Production of human -hexosaminidase A with highly phosphorylated N-glycans by the overexpression of the Ogataea minuta MNN4 gene
    Hiromi Akeboshi, Y. Kasahara, Daisuke Tsuji, Kohji Itoh, Hitoshi Sakuraba, Yasunori Chiba, Yoshifumi Jigami · 2009 · Glycobiology
  7. Single-step co-integration of multiple expressible heterologous genes into the ribosomal DNA of the methylotrophic yeast Hansenula polymorpha
    Jens Klabunde, Andre Diesel, Dorothea Waschk, Gerd Gellissen, C.P. Hollenberg, Manfred Suckow · 2002 · Applied Microbiology and Biotechnology
  8. Improved production of monoclonal antibodies through oxygen-limited cultivation of glycoengineered yeast
    Marina Berdichevsky, Marc d′Anjou, Muralidhar R. Mallem, Seemab S. Shaikh, Thomas I. Potgieter · 2011 · Journal of Biotechnology
  9. The production, characterisation and enhanced pharmacokinetics of scFv–albumin fusions expressed in Saccharomyces cerevisiae
    Leslie R. Evans, Miranda Hughes, Joanne Waters, Jason Cameron, Neil Dodsworth, David Tooth, Anthony Greenfield, Darrell Sleep · 2010 · Protein Expression and Purification
  10. Optimization of recombinant human nerve growth factor production in the psychrophilic Pseudoalteromonas haloplanktis
    Ileana Vigentini, Annamaria Merico, Maria Luisa Tutino, Concetta Compagno, Gennaro Marino · 2006 · Journal of Biotechnology
  11. Modular Protein Engineering in Emerging Cancer Therapies
    Esther Vázquez, Neus Ferrer‐Miralles, Ramón Mangues, José Luís Corchero, Simó Schwartz, Antonio Villaverde · 2009 · Current Pharmaceutical Design
  12. Large-Scale Transient Expression of Therapeutic Proteins in Mammalian Cells
    Sabine Geisse, Martin Jordan, Florian Maria Wurm · 2005 · Humana Press eBooks
  13. Design of an efficient medium for heterologous protein production in Yarrowia lipolytica: case of human interferon alpha 2b
    Najla Gasmi, Atef Ayed, Jean‐Marc Nicaud, Héla Kallel · 2011 · Microbial Cell Factories
  14. Fed-batch process for the psychrotolerant marine bacterium Pseudoalteromonas haloplanktis
    Boris Wilmes, Angelika Hartung, Michael Lalk, Manuel Liebeke, Thomas Schweder, Peter B. Neubauer · 2010 · Microbial Cell Factories
  15. Manufacturing of Biodrugs
    Niharika Sahoo Bhattacharya, Koel Choudhury, Padmavati Manchikanti · 2009 · BioDrugs
  16. Asparagine deamidation: a regulatory hourglass
    Steven Jay Weintraub · 2004 · Mechanisms of Ageing and Development
  17. Engineering building blocks for self-assembling protein nanoparticles
    Esther Vázquez, Antonio Villaverde · 2010 · Microbial Cell Factories
  18. In vivo synthesis of complexN‐glycans by expression of humanN‐acetylglucosaminyltransferase I in the filamentous fungusTrichoderma reesei
    Marleen Maras, André De Bruyn, Wouter Vervecken, Jaana M. Uusitalo, Merja E. Penttilä, Roger H. Busson, Piet A. Herdewijn, Roland Contreras · 1999 · FEBS Letters
  19. Strain and process development for the production of human cytokines in
    Adelheid Degelmann, Frank Ulrich Müller, Heike Sieber, Volker Jenzelewski, Manfred Suckow, Andreas Strasser, Gerd Gellissen · 2002 · FEMS Yeast Research
  20. Heterologous expression of Brucella abortus GroEL heat-shock protein in Lactococcus lactis
    Anderson Miyoshi, Luis G. Bermúdez‐Humarán, Luciana Abeid Ribeiro, Yves Le Loir, Sergio Costa Oliveira, Philippe Langella, Vasco Azevedo · 2006 · Microbial Cell Factories
  21. Secretion of α-Amylase from Pseudoalteromonas haloplanktis TAB23: Two Different Pathways in Different Hosts
    Maria Luisa Tutino, Ermenegilda Parrilli, Laura Giaquinto, Angela Duilio, Giovanni Sannia, Georges Feller, Gennaro Marino · 2002 · Journal of Bacteriology
  22. Rehosting of Bacterial Chaperones for High-Quality Protein Production
    Mónica Martínez‐Alonso, Verónica Toledo-Rubio, Rob J. Noad, Ugutz Unzueta, Neus Ferrer‐Miralles, Polly Roy, Antonio Villaverde · 2009 · Applied and Environmental Microbiology
  23. Soluble periplasmic production of human granulocyte colony-stimulating factor (G-CSF) in Pseudomonas fluorescens
    Hongfan Jin, Greg T. Cantin, Steven L. Maki, Lawrence Chew, Sol M. Resnick, Jerry Ngai, Diane M. Retallack · 2011 · Protein Expression and Purification
  24. Process optimization for recombinant protein production in the psychrophilic bacterium Pseudoalteromonas haloplanktis
    Maria Giuliani, Ermenegilda Parrilli, Pau Ferrer, Kristin Baumann, Gennaro Marino, Maria Luisa Tutino · 2011 · Process Biochemistry
  25. Antibody expression in protease-deficient strains of the methylotrophic yeastOgataea minuta
    Kousuke Kuroda, Yoshinori Kitagawa, Kazuo Kobayashi, Haruhiko Tsumura, Toshihiro Komeda, Eiji Mori, Kazuhiro Motoki, Shiro Kataoka, Yasunori Chiba, Yoshifumi Jigami · 2007 · FEMS Yeast Research
  26. Pichia Power: India's Biotech Industry Puts Unconventional Yeast to Work
    Chandra Shekhar · 2008 · Chemistry & Biology
  27. Expanding the molecular toolbox for Lactococcus lactis: construction of an inducible thioredoxin gene fusion expression system
    François P. Douillard, Mary O’Connell Motherway, Christian Cambillau, Douwe van Sinderen · 2011 · Microbial Cell Factories
  28. Lactococcus lactis M4, a potential host for the expression of heterologous proteins
    Noreen Suliani Mat Nanyan, Wei Yeng Hooi, Ali Baradaran, Mohamad Rosfarizan, Chin Chin Sieo, Md Illias Rosli, Khatijah Yusoff, Abdul Rahim Raha · 2011 · Microbial Cell Factories
  29. Intracellular protein production in Trichoderma reesei (Hypocrea jecorina) with hydrophobin fusion technology
    Eero Mustalahti, Markku Saloheimo, Jussi Joonas Joensuu · 2011 · New Biotechnology
  30. Characterization of the oligosaccharides assembled on the Pichia pastoris--expressed recombinant aspartic protease
    Raquel Montesino, Manfred Nimtz, O. Quintero, R. Garcia, Viviana Falcón, J.A. Cremata · 1999 · Glycobiology
  31. Antibody production in Bacillus megaterium: Strategies and physiological implications of scaling from microtiter plates to industrial bioreactors
    Florian David, Miriam Steinwand, Michael Hust, Kathrin Bohle, Anton Roß, Stefan Dübel, Ezequiel Franco‐Lara · 2011 · Biotechnology Journal
  32. ANALYZING PROTEIN DRUGS
    Jyllian N. Kemsley · 2009 · Chemical & Engineering News
  33. Systems Biology of Recombinant Protein Production in Bacillus megaterium
    Rebekka Biedendieck, Boyke Bunk, Tobias Fürch, Ezequiel Franco‐Lara, Martina Jahn, Dieter Jahn · 2010 · Springer eBooks
  34. Transport of heterologous proteins to the periplasmic space of Pseudomonas fluorescens using a variety of native signal sequences
    Diane M. Retallack, Jane C. Schneider, Jon Mitchell, Lawrence Chew, Huizhu Liu · 2007 · Biotechnology Letters
  35. Expression of SARS-coronavirus spike glycoprotein in Pichia pastoris
    C.P. Chuck, Chi Hang Wong, Larry M. C. Chow, Kwok‐Pui Fung, Mary Miu Yee Waye, Stephen Kwok‐Wing Tsui · 2008 · Virus Genes
  36. Decrease of hirudin degradation by deleting the KEX1 gene in recombinant Pichia pastoris
    Zhenhua Ni, Xiangshan Zhou, Xueqian Sun, Ya Wang, Yuanxing Zhang · 2007 · Yeast
  37. Production and purification of staphylococcal nuclease in Lactococcus lactis using a new expression-secretion system and a pH-regulated mini-reactor
    Nicolas Trémillon, Nicolas Issaly, Julien Mozo, Thomas Duvignau, Hervé Ginisty, Eric Devic, Isabelle Poquet · 2010 · Microbial Cell Factories
  38. The formulation and immunogenicity of therapeutic proteins: Product quality as a key factor.
    Joël Richard, Nadia Prang · 2010 · PubMed
  39. Integrated approach to produce a recombinant, his‐tagged human α‐galactosidase a in mammalian cells
    José Luís Corchero, Rosa Mendoza, Júlia Lorenzo, Victor Rodríguez‐Sureda, Carmen Domı́nguez, Esther Vázquez, Neus Ferrer‐Miralles, Antonio Villaverde · 2011 · Biotechnology Progress
  40. Single versus multiple bioreactor scale-up: economy for high-value products
    S.A. Rouf, Murray Moo‐Young, Jeno M. Scharer, Peter L. Douglas · 2000 · Biochemical Engineering Journal
  41. Comparison of two expression platforms in respect to protein yield and quality: Pichia pastoris versus Pichia angusta
    Matthias Mack, Marion Wannemacher, Birgit Hobl, Patricia Pietschmann, Björn M Hock · 2009 · Protein Expression and Purification
  42. Influence of production process design on inclusion bodies protein: the case of an Antarctic flavohemoglobin
    Ermenegilda Parrilli, Maria Giuliani, Gennaro Marino, Maria Luisa Tutino · 2010 · Microbial Cell Factories
  43. Cloning and Expression of Functional Full-Length Human Tissue Plasminogen Activator in Pichia pastoris
    Keivan Majidzadeh‐A, Vahid Khalaj, Fatemeh Davami, Mahdi Hemayatkar, Farzaneh Barkhordari, Adeli Ahmad, Fereidoun Mahboudi · 2010 · Applied Biochemistry and Biotechnology
  44. From laboratory to Phase I/II cancer trials with recombinant biotherapeutics
    Berend Tolner, L. Smith, Tim Hillyer, J Bhatia, P. Beckett, Lynda Robson, Surinder K. Sharma, Natalie Griffin, Wouter Vervecken, Roland Contreras et al. · 2007 · European Journal of Cancer
  45. Analytical Approaches for Assessing Aggregation of Protein Biopharmaceuticals
    Elena García‐Fruitós, Esther Vázquez, Núria González‐Montalbán, Neus Ferrer‐Miralles, Antonio Villaverde · 2011 · Current Pharmaceutical Biotechnology
  46. The inhibition of aggregation of recombinant human consensus interferon-α mutant during Pichia pastoris fermentation
    Yu-You Hao, Ju Chu, Yonghong Wang, Yingping Zhuang, Siliang Zhang · 2006 · Applied Microbiology and Biotechnology
  47. Co-production of GroELS discriminates between intrinsic and thermally-induced recombinant protein aggregation during substrate quality control
    Gemma Platas, Escarlata Rodríguez‐Carmona, Elena García‐Fruitós, Olivia Cano‐Garrido, Antonio Villaverde · 2011 · Microbial Cell Factories
  48. The delivery of peptides
    R. T. BORCHARDT, Norman Alan Mazer, J. Howard Rytting, Efraim Shek, Ehud Ziv, Elka Touítou, William I. Higuchi · 1989 · Journal of Pharmaceutical Sciences
  49. Quantitative transcript analysis of the inducible expression system pSIP: comparison of the overexpression of Lactobacillus spp. β-galactosidases in Lactobacillus plantarum
    Tien‐Thanh Nguyen, Thu‐Ha Nguyen, Thomas Maischberger, Philipp Schmelzer, Geir Mathiesen, Vincent G. H. Eijsink, Dietmar Haltrich, Clemens Peterbauer · 2011 · Microbial Cell Factories
  50. Quality Assessment of Recombinant Proteins Produced in Plants
    Giuliana Medrano, Maureen C. Dolan, Jose Condori, David N. Radin, Carole L. Cramer · 2011 · Methods in molecular biology
  51. Reflections on the immunogenicity of therapeutic proteins
    Guido Antonelli · 2008 · Clinical Microbiology and Infection
  52. Two distinct regions in the model protein Peb1 are critical for its heterologous transport out of Escherichia coli
    Lena Anton, Katariina Majander, Harri Savilahti, Liisa J. Laakkonen, Benita Westerlund‐Wikström · 2010 · Microbial Cell Factories
  53. Production of recombinant proteins and monoclonal antibodies - Techno-enonomical evaluation of the production methods
    Raisa Vermasvuori · 2009 · Aaltodoc (Aalto University)
  54. Application of the yeast‐surface‐display system for orally administered salmon calcitonin and safety assessment
    Pingnan Sun, Xuecheng Zhang, Yun‐Song Chen, Xiao‐Nan Zang · 2010 · Biotechnology Progress
  55. Cell engineering of Pseudoalteromonas haloplanktis TAC125: construction of a mutant strain with reduced exo-proteolytic activity
    Ermenegilda Parrilli, Angela Maria Cusano, Maria Giuliani, Maria Luisa Tutino · 2006 · Microbial Cell Factories
  56. Trichoderma reesei, a Promising Novel Host for Antibody Production
    Eini Nyyssönen, Sirkka Keränen · 1995 · ACS symposium series
  57. Develop Systems for Manufacturing 100,000,000 Doses of an Emergency Pharmaceutical (e.g. Vaccine or Monoclonal Antibody) Within 2 Months of Product Identification
    Toby Baldwin, Dave Estell, Janice Fung, Cherry Lin, Jeff P. Pucci, Jennifer Razo, Beverly Rider, William Throndset, Don Trimbur, Frans Van Gastel et al. · 2006
  58. Expression of human soluble TRAIL in Chlamydomonas reinhardtii chloroplast
    Yang, Zongqi, Li, Yi-nü, Chen Chen, Feng, Dong, Zhang, Zhi-fang, Liu et al. · 2006 · 中国科学通报：英文版
  59. Untitled work
    Davis · 1999 · 10.1002/(sici)1097-0290(19991120)65:4